Gilead Sciences (GILD) Non-Current Assets (2009 - 2026)
Gilead Sciences' Non-Current Assets was $35.42 billion in Q2 2026, down 13.6% from $41 billion a year earlier and down 5.9% from the prior quarter.
Powered by 
Analysis
Gilead Sciences (GILD) Non-Current Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, Non-Current Assets at Gilead Sciences came in at $40.68 billion, up 2.2% from FY2024.
- Non-Current Assets shows a five-year compound annual growth rate of -4.9% (FY2020 to FY2025).
- In earlier years, Non-Current Assets was $39.82 billion in FY2024 (-13.5%), $46.04 billion in FY2023 (-5.5%), $48.73 billion in FY2022 (-8.4%) and $53.18 billion in FY2021 (+1.5%).
- The Q2 2026 figure marks the lowest quarterly Non-Current Assets since Q3 2020.
- Compared with a year earlier, Non-Current Assets was higher in two of the last eight quarters, with an average decline of 6.1%.
- The best year-over-year quarter for Non-Current Assets over five years was Q3 2021 (growth of 77.3%); the worst was Q3 2024 (a decline of 14.3%).
- Per Business Quant data, GILD's Non-Current Assets in the three quarters before Q2 2026 was $37.64 billion (Q1 2026), $40.68 billion (Q4 2025) and $40.66 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 82.81 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 110.20 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 75.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 88.47 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 61.69 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 34.86 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 159.99 Bn |
| 10 | Vertex Pharmaceuticals | 138.90 Bn | 106.64 Bn | 2.91 Bn | 21.05 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 34.86 Bn |
| Jun 30, 2026 | 35.42 Bn |
| Mar 31, 2026 | 37.64 Bn |
| Dec 31, 2025 | 40.68 Bn |
| Sep 30, 2025 | 40.66 Bn |
| Jun 30, 2025 | 41.00 Bn |
| Mar 31, 2025 | 39.53 Bn |
| Dec 31, 2024 | 39.82 Bn |
| Sep 30, 2024 | 39.75 Bn |
| Jun 30, 2024 | 41.26 Bn |
| Mar 31, 2024 | 42.25 Bn |
| Dec 31, 2023 | 46.04 Bn |
| Sep 30, 2023 | 46.39 Bn |
| Jun 30, 2023 | 48.05 Bn |
| Mar 31, 2023 | 48.42 Bn |
| Dec 31, 2022 | 48.73 Bn |
| Sep 30, 2022 | 49.00 Bn |
| Jun 30, 2022 | 49.70 Bn |
| Mar 31, 2022 | 50.45 Bn |
| Dec 31, 2021 | 53.18 Bn |
API Access
Gilead Sciences Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=GILD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "GILD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=GILD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();